CHARLES TAYLOR, M.D.
Hematology & Oncology Physician · TULSA, OK
Individual Active NPI 1003859679
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,276 | 188,620 | $9,833,846 | $3,822,472 | $3,046,251 |
| 2023 | 1,369 | 223,893 | $12,311,337 | $4,605,818 | $3,671,325 |
| 2022 | 1,423 | 208,075 | $10,729,097 | $4,069,191 | $3,264,675 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1439 | Injection, ferric carboxymaltose, 1 mg | 15,000 | $1 | $1 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 14,300 | $0 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 11,400 | $55 | $44 |
| J1627 | Injection, granisetron, extended-release, 0.1 mg | 9,200 | $6 | $4 |
| J9299 | Injection, nivolumab, 1 mg | 8,640 | $31 | $25 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 8,200 | $0 | $0 |
| J9267 | Injection, paclitaxel, 1 mg | 8,049 | $0 | $0 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 7,380 | $49 | $39 |
| J1453 | Injection, fosaprepitant, 1 mg | 4,500 | $0 | $0 |
| J9025 | Injection, azacitidine, 1 mg | 4,400 | $0 | $0 |
| J0185 | Injection, aprepitant, 1 mg | 4,160 | $2 | $1 |
| J1434 | Injection, fosaprepitant (focinvez), 1 mg | 3,453 | $6 | $5 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 14470 | OK |
| Hematology & Oncology Physician | 207RH0003X | 15268 | AZ |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Oklahoma
- NPI 1386696011
- NPI 1548207814
- NPI 1669745667
- NPI 1932765088
- NPI 1447606348
- NPI 1205877974
- NPI 1336406685
- NPI 1609820034
See all Hematology & Oncology Physician providers in Oklahoma →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.